Exscientia lands $26 mln Series B

UK-based Exscientia, an AI-driven drug discovery company, has secured $26 million in Series B financing. The investors were Celgene Corporation, GT Healthcare Capital Partners and Evotec AG.

Source: Press Release

PE Hub Healthcare Wire delivers private equity and M&A healthcare deal activity, fundraising news, people moves, regulatory updates and much more every Thursday. Subscribe now! It’s FREE.

Find new deal opportunities, super-charge your fundraising efforts and track top managers with VCJ. Get your FREE trial! Or subscribe now!